SCHEMBL5651546

SCHEMBL5651546

COCCOc1cc2ncnc(Nc3ccc(Oc4ccc(Br)cc4)c(C4=CC(=O)C=CC4=O)c3)c2cc1OC

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.59
FBP1 P09467 1/20 0.59
EGFR P00533 5/20 0.56
FGFR1 P11362 1/20 0.52
FLT1 P17948 1/20 0.52
HDAC3 O15379 4/20 0.52
HDAC4 P56524 4/20 0.52
HDAC1 Q13547 4/20 0.52
HDAC7 Q8WUI4 4/20 0.52
HDAC2 Q92769 4/20 0.52
HDAC10 Q969S8 4/20 0.52
HDAC11 Q96DB2 4/20 0.52
HDAC8 Q9BY41 4/20 0.52
HDAC6 Q9UBN7 4/20 0.52
HDAC9 Q9UKV0 4/20 0.52
HDAC5 Q9UQL6 4/20 0.52
LCK P06239 1/20 0.50
GAK O14976 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5646837 0.94 FBP1 (0.57) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5651894 0.93 KDR (0.59) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5652242 0.92 KDR (0.69) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5652007 0.91 KDR (0.68) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5649902 0.90 KDR (0.55) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5652379 0.90 KDR (0.57) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5648157 0.89 KDR (0.58) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5650422 0.89 KDR (0.54) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5650498 0.89 KDR (0.65) KDRFBP1EGFRFGFR1FLT1
SCHEMBL5652828 0.88 KDR (0.60) KDRFBP1EGFRFGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 KDR 1/4885FBP1 2231/4885EGFR 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.